Yasuji Kouzai

498 total citations
20 papers, 322 citations indexed

About

Yasuji Kouzai is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Yasuji Kouzai has authored 20 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 12 papers in Genetics and 7 papers in Rheumatology. Recurrent topics in Yasuji Kouzai's work include Chronic Lymphocytic Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Eosinophilic Disorders and Syndromes (7 papers). Yasuji Kouzai is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Eosinophilic Disorders and Syndromes (7 papers). Yasuji Kouzai collaborates with scholars based in Japan, China and United States. Yasuji Kouzai's co-authors include Hisashi Wakita, Naoki Takezako, Satoshi Morita, Takashi Kumagai, Chikashi Yoshida, Koiti Inokuchi, Hisashi Sakamaki, Junichi Sakamoto, Chiaki Nakaseko and Shigeru Chiba and has published in prestigious journals such as Blood, Cancer Science and Respiratory Medicine.

In The Last Decade

Yasuji Kouzai

18 papers receiving 318 citations

Peers

Yasuji Kouzai
Comparison fields: 5 of 38
  • Hematology 269
  • Genetics 155
  • Rheumatology 90
  • Oncology 84
  • Immunology 63
Replace Anna Lübking with:
Anna Lübking Sweden
Alessandra Cupri Italy
Elisabetta Calistri Italy
Peter Rohoň Czechia
K Miyamura Japan
Joycelyn Sim China
Shinichiro Machida Japan
Tony Mueller Germany
D. Niederwieser Germany
N Schmitz Germany
Anna Lübking Sweden View profile →
Citations per field, relative to Yasuji Kouzai
Yasuji Kouzai · 1×
Citations per year, relative to Yasuji Kouzai
Yasuji Kouzai · 1×

Countries citing papers authored by Yasuji Kouzai

Since Specialization
Citations

This map shows the geographic impact of Yasuji Kouzai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuji Kouzai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuji Kouzai more than expected).

Fields of papers citing papers by Yasuji Kouzai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuji Kouzai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuji Kouzai. The network helps show where Yasuji Kouzai may publish in the future.

Co-authorship network of co-authors of Yasuji Kouzai

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuji Kouzai. A scholar is included among the top collaborators of Yasuji Kouzai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuji Kouzai. Yasuji Kouzai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment‐free remission
2020 ·Cancer Science ·Takashi Kumagai, Chiaki Nakaseko, Kaichi Nishiwaki, Chikashi Yoshida, Kazuteru Ohashi, Naoki Takezako, Hina Takano, Yasuji Kouzai, Tadashi Murase, Kosei Matsue, Satoshi Morita, Junichi Sakamoto, Hisashi Wakita, Hisashi Sakamaki, Koiti Inokuchi, (unknown)
10
2
Silent NK/T Cell Reactions Against Dasatinib during Sustained Deep Molecular Response before Discontinuation Are Associated with Longer Treatment-Free Remission: A Multicenter, Single-Arm, Phase 2 Study
2019 ·Blood ·Takashi Kumagai, Chiaki Nakaseko, Kaichi Nishiwaki, Chikashi Yoshida, Kazuteru Ohashi, Naoki Takezako, Hina Takano, Yasuji Kouzai, Tadashi Murase, Kosei Matsue, Satoshi Morita, Junichi Sakamoto, Hisashi Wakita, Hisashi Sakamaki, Koiti Inokuchi
1
3
Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response—The final results of the D-first study
2018 ·Leukemia Research ·Yuho Najima, Chikashi Yoshida, Noriyoshi Iriyama, Shin Fujisawa, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, (unknown), Naoki Takezako, Takashi Kumagai, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi
29
4
Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy
2017 ·International Journal of Clinical Oncology ·Masayuki Shiseki, Chikashi Yoshida, Naoki Takezako, (unknown), Takashi Kumagai, Kaichi Nishiwaki, Akira Horikoshi, Tetsuya Fukuda, Hina Takano, Yasuji Kouzai, Junji Tanaka, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi
1
5
A phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database
2017 ·Bone Marrow Transplantation ·Naoki Kurita, Masahiko Gosho, Yasuhisa Yokoyama, Takuya Kato, Naoshi Obara, Mamiko Sakata‐Yanagimoto, Yuichi Hasegawa, Naoyuki Uchida, Satoshi Takahashi, Yasuji Kouzai, Yoshiko Atsuta, Mio Kurata, Tatsuo Ichinohe, Shigeru Chiba
8
6
Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation
2017 ·Cancer Science ·Takashi Kumagai, Chiaki Nakaseko, Kaichi Nishiwaki, Chikashi Yoshida, Kazuteru Ohashi, Naoki Takezako, Hina Takano, Yasuji Kouzai, Tadashi Murase, Kosei Matsue, Satoshi Morita, Junichi Sakamoto, Hisashi Wakita, Hisashi Sakamaki, Koiti Inokuchi, (unknown)
52
7
High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study
2016 ·Bone Marrow Transplantation ·Yasuyuki Arai, Tadakazu Kondo, Akio Shigematsu, Junji Tanaka, Satoshi Takahashi, Takeshi Kobayashi, Naoyuki Uchida, Yasushi Onishi, Jun Ishikawa, Heiwa Kanamori, (unknown), Akira Yokota, Yasuji Kouzai, Minoko Takanashi, Tatsuo Ichinohe, Yoshiko Atsuta, Shuichi Mizuta, (unknown)
8
8
Discontinuation of Dasatinib after Deep Molecular Response for over 2 Years in Patients with Chronic Myelogenous Leukemia and the Unique Profiles of Lymphocyte Subsets for Successful Discontinuation: A Prospective, Multicenter Japanese Trial (D-STOP Trial)
2016 ·Blood ·Takashi Kumagai, Chiaki Nakaseko, Kaichi Nishiwaki, Chikashi Yoshida, Kazuteru Ohashi, Naoki Takezako, Hina Takano, Yasuji Kouzai, Tadashi Murase, Kosei Matsue, Satoshi Morita, Junichi Sakamoto, Hisashi Wakita, Hisashi Sakamaki, Koiti Inokuchi
28
9
Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study
2016 ·Oncology Reports ·Maki Hagihara, Noriyoshi Iriyama, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, (unknown), Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki
10
10
Association of Peripheral Regulatory T Cells with Achievement of Deep Molecular Response in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Treated with Dasatinib - the Final Results of D-First Study
2016 ·Blood ·Chikashi Yoshida, Noriyoshi Iriyama, Yuho Najima, Shin Fujisawa, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, (unknown), Naoki Takezako, Takashi Kumagai, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi
6
11
Acute Fibrinous and Organizing Pneumonia with Myelodysplastic Syndrome: Corticosteroid Monotherapy Led to Successful Ventilator Weaning
2016 ·Internal Medicine ·Mari Yamamoto, (unknown), (unknown), Yasuji Kouzai, Mikio Takamori
8
12
Cord Blood Transplantation for Multiple Myeloma: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation
2015 ·Biology of Blood and Marrow Transplantation ·Koji Kawamura, Hiroyuki Takamatsu, Takashi Ikeda, Tsunehiko Komatsu, Nobuyuki Aotsuka, (unknown), Go Yamamoto, Kentaro Watanabe, Yuju Ohno, Kosei Matsue, Yasuji Kouzai, Nobuhiro Tsukada, Ken Ishiyama, Naoyuki Anzai, Koji Kato, Ritsuro Suzuki, Kazutaka Sunami, Yoshinobu Kanda
8
13
Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy
2015 ·Blood ·Yasuyuki Arai, June Takeda, Kazunari Aoki, Tadakazu Kondo, Satoshi Takahashi, Yasushi Onishi, Yukiyasu Ozawa, Nobuyuki Aotsuka, Yasuji Kouzai, Hirohisa Nakamae, Shuichi Ota, Chiaki Nakaseko, Hiroki Yamaguchi, Koji Kato, Yoshiko Atsuta, Akiyoshi Takami
43
14
Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D‐first study
2015 ·American Journal of Hematology ·Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, (unknown), Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki
28
15
The Incidence of Pleural Effusion on Dasatinib Treatment Is Associated with CD56 Positive Cell Values One Month after Commencing Dasatinib and Achievement of an Early Molecular Response in Newly Diagnosed Chronic Myeloid Leukemia Patients: Results of a D-First Study
2014 ·Blood ·Noriyoshi Iriyama, Shin Fujisawa, Maki Hagihara, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, (unknown), Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki
1
16
Shorter halving time of BCR‐ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic‐phase chronic myeloid leukemia treated with dasatinib: Results of the D‐first study of Kanto CML study group
2014 ·American Journal of Hematology ·Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, (unknown), Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki
37
17
EFFECTIVE USE OF BLOOD PRODUCTS AMONG HOSPITALS
2010 ·Japanese Journal of Transfusion and Cell Therapy ·(unknown), (unknown), Kiyoshi Hiruma, Yoshiki Okuyama, Hiroshi Fujita, Yasuji Kouzai, (unknown), Kaori Maeda, Yukiko Kunitomo, E. Yamamoto, Yuko Takada, Tomoko Igarashi, (unknown), (unknown), Mariko Mori, (unknown), (unknown)
0
18
Comparison Of Unrelated Cord Blood Transplantation And Human Leucocyte Antigen Mismatched Unrelated Bone Marrow Transplantation For Adult Patients With Hematological Malignancy
2010 ·Biology of Blood and Marrow Transplantation ·Yoshiko Atsuta, Ritsuro Suzuki, Tokiko Nagamura‐Inoue, Shuichi Taniguchi, Satoshi Takahashi, Shunro Kai, Hisashi Sakamaki, Yasuji Kouzai, M Kasai, Takahiro Fukuda, Hiroshi Azuma, Minoko Takanashi, Shinichiro Okamoto, Masahiro Tsuchida, K Kawa, Y Kodera, Y Morishima, Shingo Kato
0
19
Incidence and Risk Factors of Early Bacterial Infections after Unrelated Cord Blood Transplantation
2009 ·Biology of Blood and Marrow Transplantation ·Makoto Yazaki, Yoshiko Atsuta, Koji Kato, Shunichi Kato, Shuichi Taniguchi, Satoshi Takahashi, Hiroyasu Ogawa, Yasuji Kouzai, Takeshi Kobayashi, Masami Inoue, Ryōji Kobayashi, Tokiko Nagamura‐Inoue, Hiroshi Azuma, Minoko Takanashi, Shunro Kai, Masao Nakabayashi, Hidehiko Saito
32
20
Endobronchial non-Hodgkin's lymphoma
1989 ·Respiratory Medicine ·Ryuji Ieki, Hajime Goto, Yasuji Kouzai, Takayuki Morisaki, Shigetaka Asano, (unknown), Fumimaro Takaku
12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Lübking Breakdown of academic impact, for papers by Alessandra Cupri Breakdown of academic impact, for papers by Elisabetta Calistri Breakdown of academic impact, for papers by Peter Rohoň Breakdown of academic impact, for papers by K Miyamura Breakdown of academic impact, for papers by Joycelyn Sim Breakdown of academic impact, for papers by Shinichiro Machida Breakdown of academic impact, for papers by Tony Mueller Breakdown of academic impact, for papers by D. Niederwieser Breakdown of academic impact, for papers by N Schmitz
Rankless by CCL
2026